Literature DB >> 30546603

Cardiac sarcoidosis, the complete atrioventricular block of which was completely recovered by intravenous steroid pulse therapy.

Hiroaki Watanabe1, Kazuo Eguchi1, Toshinobu Saitou1, Masahisa Shimpo1, Michiaki Hiroe2, Kazuomi Kario1.   

Abstract

Atrioventricular block (AVB) in individuals with cardiac sarcoidosis (CS) is one of the major complications caused by inflammation of the conducting system of the heart, as a sign of worse prognosis. We report the case of a 53-year-old Japanese woman whose electrocardiogram showed complete AVB by the clinical diagnosis of CS. We administered intravenous methylpredonisolone (1 g/day) for 3 days. On the second day of steroid pulse therapy, the complete AVB improved to sinus rhythm of 1st degree AVB and complete right bundle branch block. Normal sinus rhythm was then observed after oral steroid therapy. These results suggest that in cases of complete AVB, steroid pulse therapy with a strong anti-inflammatory effect may be recommended first. <Learning objective: This case illustrates a typical case of CS with complete AVB, but the cardiac contraction was normal. In this setting, steroid pulse therapy may be effective when (1) the active inflammation of the conduction system can be suppressed by steroid pulse therapy; (2) the time to start steroid therapy is short enough to recover.>.

Entities:  

Keywords:  Cardiac sarcoidosis; Complete atrioventricular block; Steroid pulse therapy

Year:  2015        PMID: 30546603      PMCID: PMC6281864          DOI: 10.1016/j.jccase.2015.09.003

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Pulse steroid therapy.

Authors:  Aditi Sinha; Arvind Bagga
Journal:  Indian J Pediatr       Date:  2008-11-21       Impact factor: 1.967

2.  Cardiac magnetic resonance imaging for assessment of steroid therapy in a patient with cardiac sarcoidosis and a magnetic resonance-conditional pacemaker.

Authors:  Tamami Kono; Akiyoshi Ogimoto; Makoto Saito; Kaori Fujimoto; Akira Fujii; Teruyoshi Uetani; Takayuki Nagai; Kazuhisa Nishimura; Katsuji Inoue; Jun Suzuki; Takafumi Okura; Tomoyuki Kido; Masao Miyagawa; Teruhito Mochizuki; Jitsuo Higaki
Journal:  Int J Cardiol       Date:  2014-08-02       Impact factor: 4.164

3.  Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.

Authors:  Makoto Orii; Kumiko Hirata; Takashi Tanimoto; Shingo Ota; Yasutsugu Shiono; Takashi Yamano; Yoshiki Matsuo; Yasushi Ino; Tomoyuki Yamaguchi; Takashi Kubo; Atsushi Tanaka; Takashi Akasaka
Journal:  Heart Rhythm       Date:  2015-06-22       Impact factor: 6.343

4.  Cardiac sarcoidosis: a retrospective study of 41 cases.

Authors:  Catherine Chapelon-Abric; Dominique de Zuttere; Pierre Duhaut; Pierre Veyssier; Bertrand Wechsler; Du Le Thi Huong; Christian de Gennes; Thomas Papo; Olivier Blétry; Pierre Godeau; Jean-Charles Piette
Journal:  Medicine (Baltimore)       Date:  2004-11       Impact factor: 1.889

5.  Surgical site infections: reanalysis of risk factors.

Authors:  Debra L Malone; Thomas Genuit; J Kathleen Tracy; Christopher Gannon; Lena M Napolitano
Journal:  J Surg Res       Date:  2002-03       Impact factor: 2.192

6.  Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone.

Authors:  Y Yazaki; M Isobe; M Hiroe; S Morimoto; S Hiramitsu; T Nakano; T Izumi; M Sekiguchi
Journal:  Am J Cardiol       Date:  2001-11-01       Impact factor: 2.778

Review 7.  The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities.

Authors:  Kyoko Soejima; Hirotaka Yada
Journal:  J Cardiovasc Electrophysiol       Date:  2009-01-09

8.  Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block.

Authors:  Yasuchika Kato; Shin-ichiro Morimoto; Akihisa Uemura; Shinya Hiramitsu; Teruo Ito; Hitoshi Hishida
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2003-06       Impact factor: 0.670

9.  Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis.

Authors:  Kimikazu Banba; Kengo Fukushima Kusano; Kazufumi Nakamura; Hiroshi Morita; Aiko Ogawa; Fuyo Ohtsuka; Keiko Ohta Ogo; Nobuhiro Nishii; Atsuyuki Watanabe; Satoshi Nagase; Satoru Sakuragi; Tohru Ohe
Journal:  Heart Rhythm       Date:  2007-06-16       Impact factor: 6.343

10.  Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis.

Authors:  Miyako Morooka; Masao Moroi; Kimiichi Uno; Kimiteru Ito; Jin Wu; Takashi Nakagawa; Kazuo Kubota; Ryogo Minamimoto; Yoko Miyata; Momoko Okasaki; Osamu Okazaki; Yoshihito Yamada; Tetsuo Yamaguchi; Michiaki Hiroe
Journal:  EJNMMI Res       Date:  2014-01-02       Impact factor: 3.138

  10 in total
  2 in total

1.  Controversies in the Treatment of Cardiac Sarcoidosis.

Authors:  Ogugua Ndili Obi; Elyse E Lower; Robert P Baughman
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-06-29       Impact factor: 1.803

2.  A Case of Large Sarcoid Choroidal Granuloma Treated with Steroid Pulse Therapy.

Authors:  Takatoshi Kobayashi; Nanae Takai; Takaki Sato; Rei Tada; Eri Maruyama; Hiromi Shouda; Takako Okamoto; Kohichi Maruyama; Tsunehiko Ikeda
Journal:  Case Rep Ophthalmol       Date:  2020-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.